High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Regression Models and Life-Tables

Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423

Regression Models and Life-Tables

Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297

High density lipoprotein as a protective factor against coronary heart disease

Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881

A SIMPLIFIED METHOD FOR THE ESTIMATION OF TOTAL CHOLESTEROL IN SERUM AND DEMONSTRATION OF ITS SPECIFICITY

Abell, L. L., Levy, B. B., Brodie, B. B., & Kendall, F. E. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50907-3 · Cited by 3,085

Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels

Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512

Epidemiological approaches to heart disease: the Framingham study

Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148

Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts

Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654

High density lipoprotein metabolism.

Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212

A 2-year study on the beneficial effects of 17β-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone

van der Mooren, M. J., Demacker, P. N. M., Thomas, C. M. G., Borm, G. F., & Rolland, R. (1993) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(93)90237-7 · Cited by 46

Longitudinal Trajectories of Cholesterol from Midlife through Late Life according to Apolipoprotein E Allele Status

Downer, B. G., Estus, S., Katsumata, Y., & Fardo, D. W. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph111010663 · Cited by 51

LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection

Orsoni, A., Saheb, S., Levels, J. H. M., Dallinga‐Thie, G. M., Atassi, M., Bittar, R., Robillard, P., Bruckert, É., Kontush, A., Carrié, A., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.p016816 · Cited by 45

Cacao Polyphenols Influence the Regulation of Apolipoprotein in HepG2 and Caco2 Cells

Yasuda, A., Natsume, M., Osakabe, N., Kawahata, K., & Koga, J. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf103820b · Cited by 45

Effects of bariatric surgery on HDL structure and functionality: results from a prospective trial

Zvintzou, E., Skroubis, G., Chroni, A., Πετροπούλου, Π.-Ι., Gkolfinopoulou, C., Sakellaropoulos, G. C., Gantz, D., Mihou, I., Kalfarentzos, F., & Kypreos, K. E. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.05.001 · Cited by 46

Cholesterol Uptake Capacity: A New Measure of HDL Functionality for Coronary Risk Assessment

Harada, A., Toh, R., Murakami, K., Kiriyama, M., Yoshikawa, K., Miwa, K., Kubo, T., Irino, Y., Mori, K., Tanaka, N. K., et al. (2017) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.022913 · Cited by 46

Differences in Gut Microbial and Serum Biochemical Indices Between Sows With Different Productive Capacities During Perinatal Period

Shao, Y., Zhou, J. W., Xiong, X., Zou, L., Kong, X., Tan, B., & Yin, Y. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03047 · Cited by 45

High-density lipoprotein cholesterol and all-cause mortality by sex and age: a prospective cohort study among 15.8 million adults

Yi, S., Park, S.-J., Yi, J., Ohrr, H., & Kim, H. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa243 · Cited by 45

Pueraria Mirifica Phytoestrogens Improve Dyslipidemia in Postmenopausal Women Probably by Activating Estrogen Receptor Subtypes

Okamura, S., Sawada, Y., Satoh, T., Sakamoto, H., Saito, Y., Sumino, H., Takizawa, T., Kogure, T., Chaichantipyuth, C., Higuchi, Y., et al. (2008) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.216.341 · Cited by 46

Epidemiology of low HDL-cholesterol: results of studies and surveys

Bruckert, É. (2006) · European Heart Journal Supplements · doi:10.1093/eurheartj/sul036 · Cited by 48

Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America

Teh, E., Dolphin, P. J., Breckenridge, W. C., & Tan, M.-H. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33905-5 · Cited by 45

Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor.

Crutchley, D. J., McPhee, G., Terris, M., & Canossa-Terris, M. A. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/atv81.9.6.2511826 · Cited by 45

The dilemma of the metabolic syndrome in children and adolescents: disease or distraction?

Jones, K. L. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00212.x · Cited by 46

High‐density Lipoprotein Apolipoprotein A‐I Kinetics in Obesity

Ooi, E. M. M., Watts, G. F., Farvid, M. S., Chan, D. C., Allen, M. C., Zilko, S. R., & Barrett, P. H. R. (2005) · Obesity Research · doi:10.1038/oby.2005.118 · Cited by 44

Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: Additive effects of combination treatment on lipid regulation

Zambón, D., Ros, E., Rodrı́guez-Villar, C., Laguna, J. C., Vázquez, M., Sanllehy, C., Casals, E., Sol, J. M., & Hernández, G. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90009-4 · Cited by 45

The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients

Cortellaro, M., Boschetti, C., Cofrancesco, E., Zanussi, C., Catalano, M., DEGAETANO, G., Gabrielli, L., Lombardi, B., Specchia, G., & Tavazzi, L. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90105-c · Cited by 45

Alcohol consumption and its relation to lipid-based cardiovascular risk factors among middle-aged women: the role of HDL3 cholesterol

Sillanaukee, P., Koivula, T. A., Jokela, H., Pitkäjärvi, T., & Seppä, K. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00369-5 · Cited by 43

Effects of exercise training on metabolic syndrome risk factors in post-menopausal women – A systematic review and meta-analysis of randomised controlled trials

Tan, A. S. Y., Thomas, R., Campbell, M. D., Prior, S. L., Bracken, R. M., & Churm, R. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.01.008 · Cited by 60

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis

Chyu, K., & Shah, P. K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00187 · Cited by 44

HDLs activate ADAM17‐dependent shedding

Tellier, E., Canault, M., Poggi, M., Bonardo, B., Nicolay, A., Alessi, M., Nalbone, G., & Peiretti, F. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21265 · Cited by 44

High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study

Arts, E., Fransen, J., Lemmers, H., Stalenhoef, A. F. H., Joosten, L. A. B., van Riel, P. L. C. M., & Popa, C. D. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3842 · Cited by 44

Peanuts, Peanut Oil, and Fat Free Peanut Flour Reduced Cardiovascular Disease Risk Factors and the Development of Atherosclerosis in Syrian Golden Hamsters

Stephens, A. M., Dean, L. L., Davis, J. P., Osborne, J. A., & Sanders, T. H. (2010) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.01569.x · Cited by 44

Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function

Zhang, L., Yermalitsky, V. N., Huang, J., Pleasent, T., Borja, M. S., Oda, M. N., Jerome, W. G., Yancey, P. G., Linton, M. F., & Davies, S. S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001099 · Cited by 43

Old and new cardiovascular risk factors: from unresolved issues to new opportunities

Maas, R., & Böger, R. H. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00028-x · Cited by 44

The effect of neopuntia® on blood lipid parameters—Risk factors for the metabolic syndrome (Syndrome χ)

Linarès, E., Thimonier, C., & Degré, M. (2007) · Advances in Therapy · doi:10.1007/bf02877717 · Cited by 44

PXR agonism decreases plasma HDL levels in ApoE⁎3-Leiden.CETP mice

de Haan, W., der Weij, J. D. V.-V., Mol, I. M., Hoekstra, M., Romijn, J. A., Jukema, J. W., Havekes, L. M., Princen, H. M. G., & Rensen, P. C. N. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.12.008 · Cited by 44

Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?

Mani, P., & Rohatgi, A. K. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0521-x · Cited by 47

Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL‐cholesterol levels: a 12‐week randomized trial

Després, J., Lemieux, I., Salomon, H., & Delaval, D. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00988.x · Cited by 44

Age‐related increased susceptibility of high‐density lipoproteins (HDL) to in vitro oxidation induced by γ‐radiolysis of water

Khalil, A., Jay‐Gerin, J., & Fülöp, T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01058-8 · Cited by 44

Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness

F�ger, B., Luef, G. J., Ritsch, A., Schmidauer, C., Doblinger, A., Lechleitner, M., Aichner, F., & Patsch, J. R. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00192888 · Cited by 44

Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection

Sakai, N., Santamarina-Fojo, S., Yamashita, S., Matsuzawa, Y., & Brewer, H. B. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37289-8 · Cited by 44

Saturated fats, cholesterol, and dietary compliance.

Henkin, Y., Garber, D. W., Osterlund, L., & Darnell, B. E. (1992) · PubMed · Cited by 44

Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: Have they been adequately evaluated?

Fetters, J. K., Peterson, E. D., Shaw, L. J., Newby, L. K., & Califf, R. M. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90289-6 · Cited by 44

Effects of add-on lipid-modifying therapy on top of background statin treatment on major cardiovascular events: A meta-analysis of randomized controlled trials

Ip, C.-K., Jin, D.-M., Gao, J.-J., Meng, Z., Meng, J., Tan, Z., Wang, J.-F., & Geng, D.-F. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.04.228 · Cited by 43

Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review and network meta-analysis of randomized controlled trials

Xia, J., Yu, J., Xu, H., Zhou, Y., Li, H., Yin, S., Xu, D., Wang, Y., Xia, H., Liao, W., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106647 · Cited by 44

Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?

Razavi, A. C., Jain, V., Grandhi, G. R., Patel, P., Karagiannis, A. D., Patel, N. H., Dhindsa, D. S., Liu, C., Desai, S., Almuwaqqat, Z., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad406 · Cited by 47

Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

Penno, G., Solini, A., Zoppini, G., Fondelli, C., Trevisan, R., Vedovato, M., Gruden, G., Lamacchia, O., Pontiroli, A. E., Arosio, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125512 · Cited by 43

Diet and Exercise Interventions among Overweight and Obese Lactating Women: Randomized Trial of Effects on Cardiovascular Risk Factors

Brekke, H. K., Bertz, F., Rasmussen, K. M., Bosaeus, I. G., Ellegård, L., & Winkvist, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088250 · Cited by 43

Association of Cigarette Smoking and Metabolic Syndrome in a Puerto Rican Adult Population

Calo, W. A., Ortiz, A. P., Suarez, E. L., Guzmán, M., Perez, C. M., & Pérez, C. M. (2012) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-012-9660-0 · Cited by 43

Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?

Tardif, J. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.018 · Cited by 43

Methyl protodioscin increases ABCA1 expression and cholesterol efflux while inhibiting gene expressions for synthesis of cholesterol and triglycerides by suppressing SREBP transcription and microRNA 33a/b levels

Ma, W., Ding, H., Gong, X., Liu, Z., Lin, Y., Zhang, Z., & Lin, G. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.034 · Cited by 43

Relation of Black Race Between High Density Lipoprotein Cholesterol Content, High Density Lipoprotein Particles and Coronary Events (from the Dallas Heart Study)

Chandra, A., Neeland, I. J., Das, S. R., Khera, A., Turer, A. T., Ayers, C. R., McGuire, D. K., & Rohatgi, A. K. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.015 · Cited by 43

Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis

Affan, E. T., Praveen, D., Chow, C. K., & Neal, B. C. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-21 · Cited by 48

ATP-binding cassette transporter A1 and HDL metabolism: effects of fatty acids

Lee, J., Park, Y., & Koo, S. I. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.001 · Cited by 43

Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients

Franceschini, G., Favari, E., Calabresi, L., Simonelli, S., Bondioli, A., Adorni, M. P., Zimetti, F., Gomaraschi, M., Coutant, K., Rossomanno, S., et al. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.06.007 · Cited by 42

Inflammation and skin cholesterol in LDLr−/−, apoA-I−/− mice: link between cholesterol homeostasis and self-tolerance?

Zabalawi, M., Bharadwaj, M. S., Horton, H., Cline, M., Willingham, M. C., Thomas, M. J., & Sorci‐Thomas, M. G. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600370-jlr200 · Cited by 43

Influence of crocetin on high-cholesterol diet induced atherosclerosis in rats via anti-oxidant activity together with inhibition of inflammatory response and p38 MAPK signaling pathway

Diao, S.-L., Sun, J., Ma, B., Li, X., & Wang, D. (2016) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2016.11.005 · Cited by 43

Composition-function analysis of HDL subpopulations: influence of lipid composition on particle functionality

Niisuke, K., Kuklenyik, Z., Horvath, K. V., Gardner, M. S., Toth, C. A., & Asztalos, B. F. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra119000258 · Cited by 45

Importancia del colesterol HDL en la aterotrombosis. ¿De dónde venimos? ¿Hacia dónde vamos?

Badimón, J. J., Santos‐Gallego, C. G., & Badimón, L. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70150-0 · Cited by 45

CHOLESTERYL ESTER TRANSFER PROTEIN: ITS ROLE IN PLASMA LIPID TRANSPORT

Barter, P. J., & Rye, K. (1994) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1994.tb02569.x · Cited by 43

High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways

Xu, J., Qian, J., Xie, X., Li, L., Ma, J., Huang, Z., Fu, M., Zou, Y., & Ge, J. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1422-8 · Cited by 43

Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women

Modena, M. G. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00074-6 · Cited by 43

Serum cholesterol is a risk factor for myocardial infarction in elderly men and women: the Rotterdam Study

Houterman, S., Verschuren, W. M. M., Hofman, A., & Witteman, J. C. M. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00525.x · Cited by 43

Interrelationships Between Human Apolipoprotein A-I and Apolipoproteins B-48 and B-100 Kinetics Using Stable Isotopes

Welty, F. K., Lichtenstein, A. H., Barrett, P. H. R., Dolnikowski, G. G., & Schaefer, E. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137975.14996.df · Cited by 43

Flow-mediated vasodilation is not impaired when HDL-cholesterol is lowered by substituting carbohydrates for monounsaturated fat

de Rose, N. M., Bots, M. L., Siebelink, E., Schouten, E. G., & Katan, M. B. (2001) · British Journal Of Nutrition · doi:10.1079/bjn2001365 · Cited by 43

Women, High-Density Lipoprotein Cholesterol, and Exercise

Taylor, P. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410100014003 · Cited by 43

Sustained Expression of Human Apolipoprotein A-I after Adenoviral Gene Transfer in C57BL/6 Mice: Role of Apolipoprotein A-I Promoter, Apolipoprotein A-I Introns, and Human Apolipoprotein E Enhancer

Geest, B. D., Linthout, S. V., Lox, M., Collen, D., & Holvoet, P. (2000) · Human Gene Therapy · doi:10.1089/10430340050016193 · Cited by 43

Non–High-Density Lipoprotein Cholesterol Level as Potential Risk Predictor and Therapy Target

Grundy, S. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1379 · Cited by 43

Global prevalence of dyslipidaemia in adult populations: a systematic review protocol

Mohamed-Yassin, M.-S., Baharudin, N., Abdul-Razak, S., Ramli, A. S., & Lai, N. M. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049662 · Cited by 44

Breastfeeding is protective to diabetes risk in young adults: a longitudinal study

Mamun, A. A., O'Callaghan, M. J., Williams, G. M., Najman, J. M., Callaway, L. K., & McIntyre, D. H. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0690-z · Cited by 45

Is moderate intensity exercise training combined with high intensity interval training more effective at improving cardiorespiratory fitness than moderate intensity exercise training alone?

Roxburgh, B. H., Nolan, P. B., Weatherwax, R. M., & Dalleck, L. C. (2014) · PubMed Central · Cited by 45

Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control Study

Li, Z., Du, X., Guo, X., Tang, R., Jiang, C., Liu, N., Chang, S., Yu, R., Long, D., Bai, R., et al. (2018) · Medical Science Monitor · doi:10.12659/msm.907580 · Cited by 42

The pleiotropic vasoprotective functions of high density lipoproteins (HDL)

Boyce, G. K., Button, E. B., Sonja, S. V., & Wellington, C. L. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160103 · Cited by 41

The effect of Psidium guajava aqueous leaf extract on liver glycogen enzymes, hormone sensitive lipase and serum lipid profile in diabetic rats

Tella, T., Masola, B., & Mukaratirwa, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.137 · Cited by 45

Differences in Levels of Biomarkers of Potential Harm Among Users of a Heat-Not-Burn Tobacco Product, Cigarette Smokers, and Never-Smokers in Japan: A Post-Marketing Observational Study

Sakaguchi, C., Nagata, Y., Kikuchi, A., Takeshige, Y., & Minami, N. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab014 · Cited by 42

Serum Cholesterol, Lifestyle, Working Capacity and Quality of Life in Patients with Coronary Artery Disease. Experiences from a Hospital-based Secondary Prevention Programme

Carlsson, R. (1998) · Scandinavian Cardiovascular Journal · doi:10.1080/140174398427956-1 · Cited by 42

Deficiency of Cholesteryl Ester Transfer Protein

Ritsch, A., Drexel, H., Amann, F. W., Pfeifhofer‐Obermair, C., & Patsch, J. R. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3433 · Cited by 40

Cholesterol Efflux Effect of High Density Lipoprotein is Impaired by Whole Cigarette Smoke Extracts Through Lipid Peroxidation

Ueyama, K., Yokode, M., Arai, H., Nagano, Y., Zhi-Xiang, L., Cho, M., & Kita, T. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00214-1 · Cited by 41

Chronic Kidney Disease: A Risk Factor for Cardiovascular Disease

Wali, R. K., & Henrich, W. L. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2005.03.007 · Cited by 42

High preβ1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet

Miida, T., Yamaguchi, T., Tsuda, T., & Okada, M. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00011-2 · Cited by 42

Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles.

Katzel, L. I., Krauss, R. M., & Goldberg, A. P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1121 · Cited by 41

Sustained expression of human apo A-I following adenoviral gene transfer in mice

Geest, B. D., Linthout, S. V., & Collen, D. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301374 · Cited by 42

Lipoproteínas de alta densidade: aspectos metabólicos, clínicos, epidemiológicos e de intervenção terapêutica. Atualização para os clínicos

Forti, N. A., & Diament, J. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001800019 · Cited by 43

Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia

Ou, J., Xu, Y., Chen, H.-H., Fan, X., Gao, K., Wang, J., Guo, X., Wu, R., & Zhao, J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2850-6 · Cited by 41

Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels

Hausenloy, D. J., & Yellon, D. M. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832ebfe7 · Cited by 42

β-Sitosterol oxidation products attenuate vasorelaxation by increasing reactive oxygen species and cyclooxygenase-2

Yang, C., Chen, Z., Wong, S. L., Liu, J., Liang, Y. T., Lau, C. W., Lee, H. K., Huang, Y., & Tsang, S. Y. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs370 · Cited by 41

Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease

de Fost, M., Langeveld, M., Franssen, R., Hutten, B. A., Groener, J. E. M., de Groot, E., Mannens, M. M. A. M., Bikker, H., Aerts, J. M. F. G., Kastelein, J. J. P., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.027 · Cited by 41

A cross-sectional assessment of metabolic syndrome in HIV-infected people of low socio-economic status receiving antiretroviral therapy

Tiozzo, E., Konefal, J., Adwan, S., Martinez, L. A., Villabona, J., Lopez, J., Cutrono, S. E., Mehdi, S. M. A., Rodriguez, A. E., Woolger, J. M., et al. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0008-5 · Cited by 41

Predictive scores for identifying patients with type 2 diabetes mellitus at risk of acute myocardial infarction and sudden cardiac death

Lee, S., Zhou, J., Guo, C. L., Wong, W. T., Liu, T., Wong, I. C. K., Jeevaratnam, K., Zhang, Q., & Tse, G. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.240 · Cited by 42

Relation of Clinical Benefit of Raising High-Density Lipoprotein Cholesterol to Serum Levels of Low-Density Lipoprotein Cholesterol in Patients With Coronary Heart Disease (from the Bezafibrate Infarction Prevention Trial)

Goldenberg, I., Benderly, M., Sidi, R., Boyko, V., Tenenbaum, A., Tanné, D., & Behar, S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.08.033 · Cited by 43

Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism

Ruel, I. L., Couture, P., Cohn, J. S., Bensadoun, A., Marcil, M., & Lamarche, B. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400090-jlr200 · Cited by 41

Dietary and serum lipids in individuals with spinal cord injury living in the community.

Moussavi, R. M., Ribas-Cardús, F., Rintala, D. H., & Rodriguez, G. P. (2001) · PubMed · Cited by 41

Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa Heart Study

Chen, W., Srinivasan, S. R., Elkasabany, A., Ellsworth, D. L., Boerwinkle, E., & Berenson, G. S. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00508-1 · Cited by 42

Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol

Bergheanu, S. C., van Tol, A., Dallinga‐Thie, G. M., Liem, A. H., Dunselman, P. H. J. M., van der Bom, J. G., & Jukema, J. W. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x226104 · Cited by 41

R219K polymorphism of the ABCA1 gene and its modulation of the variations in serum high-density lipoprotein cholesterol and triglycerides related to age and adiposity in white versus black young adults. The bogalusa heart study

Srinivasan, S. R., Li, S., Chen, W., Boerwinkle, E., & Berenson, G. S. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00076-3 · Cited by 41

Expanded clinical evaluation of lovastatin (EXCEL) study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia

Bradford, R. H., Shear, C. L., Chremos, A. N., Franklin, F. A., Nash, D. T., Hurley, D. P., Dujovne, C. A., Pool, J. L., Schnaper, H. W., Hesney, M., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90052-y · Cited by 41

Effect of physical training on lipids, lipoproteins, apolipoproteins, lipases, and endogenous sex hormones in men with premature myocardial infarction

Mendoza, S. G., Carrasco, H., Zerpa, A., Briceño, Y., Rodriguez, F., Speirs, J., & Glueck, C. J. (1991) · Metabolism · doi:10.1016/0026-0495(91)90147-o · Cited by 41

Lipoproteins and Their Effects on the Cardiovascular System

Das, P., & Ingole, N. (2023) · Cureus · doi:10.7759/cureus.48865 · Cited by 46

Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice

Gordts, S. C., Muthuramu, I., Nefyodova, E., Jacobs, F., Craeyveld, E. V., & Geest, B. D. (2013) · Gene Therapy · doi:10.1038/gt.2013.30 · Cited by 40

The role of cardiorespiratory fitness on plasma lipid levels

Parto, P., Lavie, C. J., Swift, D. L., & Sui, X. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1092384 · Cited by 40

The effects of Montmorency tart cherry juice supplementation and FATMAX exercise on fat oxidation rates and cardio-metabolic markers in healthy humans

Desai, T., Bottoms, L. M., & Roberts, M. G. (2018) · European Journal of Applied Physiology · doi:10.1007/s00421-018-3978-9 · Cited by 40

Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42 months of treatment

Thurberg, B. L., Díaz, G. A., Lachmann, R., Schiano, T. D., Wasserstein, M., Ji, A., Zaher, A., & Peterschmitt, M. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.06.010 · Cited by 41

Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL

Hui, N., Barter, P. J., Ong, K. L., & Rye, K. (2019) · Clinical Science · doi:10.1042/cs20190873 · Cited by 40

Impact of Aortic Stiffness on Cardiovascular Disease in Patients With Chest Pain * Assessment With Direct Intra-Arterial Measurement

Choi, C. U., Park, E. B., Suh, S. Y., Kim, J. W., Kim, E. J., Rha, S., Seo, H. S., Oh, D. J., & Park, C. G. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.07.004 · Cited by 40

Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects

Fiegenbaum, M., Silveira, F. R., Sand, C. R. V. D., der Sand, L. C. V., Ferreira, M. E. W., Pires, R. C., & Hutz, M. H. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.06.005 · Cited by 40

High-density lipoprotein antagonizes oxidized low-density lipoprotein by suppressing oxygen free-radical formation and preserving nitric oxide bioactivity

Lee, C., CHIEN, C., Chang, P., HSIEH, M., Jui, H., LIAU, C., Hsu, S. H.-J., & Lee, Y. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.029 · Cited by 40

Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II

Moyad, M. A., Barada, J. H., Lue, T. F., Mulhall, J. P., Goldstein, I., & Fawzy, A. (2004) · Urologic Clinics of North America · doi:10.1016/j.ucl.2004.01.007 · Cited by 40

Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis

Arca, M., Montali, A., Ombres, D., Battiloro, E., Campagna, F., Ricci, G., & Verna, R. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600510.x · Cited by 41

Increased meal frequency attenuates fat-free mass losses and some markers of health status with a portion-controlled weight loss diet

Alencar, M. K., Beam, J. R., McCormick, J. J., White, A. C., Salgado, R. M., Kravitz, L. R., Mermier, C. M., Gibson, A. L., Conn, C. A., Kolkmeyer, D., et al. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.03.003 · Cited by 32

Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans

Cohn, J. S., Batal, R., Tremblay, M., Jacques, H., Veilleux, L., Rodriguez, C., Mamer, O., & Davignon, J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300209-jlr200 · Cited by 35

Research Progress on Relationship of High Density Lipoprotein Cholesterol and Coronary Heart Disease

Li-ron, Y. (2009) · Chinese Journal of General Practice

High density lipoprotein as a protective factor against coronary heart disease

Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059

High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men.

Kitamura, A., Iso, H., Naito, Y., Iida, M., Konishi, M., Folsom, A. R., Sato, S., Kiyama, M., Nakamura, M., & Sankai, T. (1994) · Circulation · doi:10.1161/01.cir.89.6.2533 · Cited by 212

Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels

Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512

Serum lipoproteins as risk factors: recent epidemiologic studies in individuals with and without prevalent cardiovascular disease

Tyroler, H. A. (1990) · European Heart Journal · doi:10.1093/eurheartj/11.suppl_h.21 · Cited by 9